What's new

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised

Jun 6, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Date of authorisation: 12/12/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

EMEA-001039-PIP04-23

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Comirnaty, Tozinamera...

Related Posts

European shortages monitoring platform (ESMP): updates and question and answer (Q&A) clinic for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 June 2025, 10:30 (CEST) to 24 June 2025, 12:00 (CEST)

European shortages monitoring platform (ESMP): updates ...

May 14, 2025  0

Network Data Steering Group workplan 2025-2028

May 19, 2025  0

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0